Corteva, Inc. (NYSE:CTVA) Shares Sold by HB Wealth Management LLC

HB Wealth Management LLC trimmed its position in Corteva, Inc. (NYSE:CTVAFree Report) by 42.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,893 shares of the company’s stock after selling 3,673 shares during the quarter. HB Wealth Management LLC’s holdings in Corteva were worth $235,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of CTVA. Moneta Group Investment Advisors LLC boosted its holdings in Corteva by 110,628.9% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 7,904,934 shares of the company’s stock valued at $464,652,000 after purchasing an additional 7,897,795 shares during the last quarter. Norges Bank acquired a new position in Corteva in the 4th quarter valued at about $328,936,000. Harris Associates L P acquired a new position in Corteva in the 3rd quarter valued at about $246,423,000. Van ECK Associates Corp boosted its holdings in Corteva by 78.7% in the 3rd quarter. Van ECK Associates Corp now owns 7,645,091 shares of the company’s stock valued at $391,123,000 after purchasing an additional 3,366,106 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its holdings in Corteva by 283.5% in the 2nd quarter. Wells Fargo & Company MN now owns 4,482,718 shares of the company’s stock valued at $256,860,000 after purchasing an additional 3,313,768 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Trading Up 1.2 %

Shares of NYSE:CTVA opened at $57.67 on Friday. Corteva, Inc. has a 52 week low of $43.22 and a 52 week high of $63.37. The company’s 50 day moving average is $52.95 and its two-hundred day moving average is $49.79. The company has a current ratio of 1.56, a quick ratio of 0.90 and a debt-to-equity ratio of 0.09. The company has a market cap of $40.30 billion, a PE ratio of 56.54, a P/E/G ratio of 1.47 and a beta of 0.77.

Corteva (NYSE:CTVAGet Free Report) last announced its quarterly earnings data on Thursday, February 1st. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.09. Corteva had a net margin of 4.27% and a return on equity of 7.43%. The company had revenue of $3.71 billion for the quarter, compared to the consensus estimate of $3.54 billion. During the same period in the prior year, the firm posted $0.16 EPS. Equities analysts predict that Corteva, Inc. will post 2.87 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date was Thursday, February 29th. Corteva’s dividend payout ratio is presently 62.75%.

Analyst Ratings Changes

CTVA has been the topic of several recent analyst reports. BNP Paribas upgraded shares of Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 price objective on the stock in a report on Friday, February 2nd. Barclays upped their price objective on shares of Corteva from $50.00 to $55.00 and gave the stock an “equal weight” rating in a report on Friday, February 2nd. Oppenheimer upped their price objective on shares of Corteva from $60.00 to $62.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Wolfe Research initiated coverage on shares of Corteva in a report on Friday, March 1st. They issued an “outperform” rating and a $67.00 price objective on the stock. Finally, Mizuho decreased their price objective on shares of Corteva from $59.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 1st. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $63.14.

View Our Latest Analysis on CTVA

About Corteva

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Read More

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.